Equistone inks agreement to acquire French group Vulcain Ingénierie
By Nikita Chaurasia  Date: 2019-06-26

Equistone inks agreement to acquire French group Vulcain Ingénierie

The deal with Equistone will provide Vulcain with the support and resources that it needs to achieve global expansion

Equistone Partners Europe, a leading marketing private equity firm present across four countries, recently announced that it has entered into an agreement with Initiative & Finance, NiXEN Partners and the management team for acquiring Vulcain Ingénierie. It has been reported that the representatives of the employees and relevant authorities are yet to approve the deal.

According to reliable sources, Vulcain Ingénierie, a French engineering consultancy group, has gained a strong reputation in the market among its contracting parties due to its specialist positioning.

Partners at Equistone, Gregoire Chatillon and Stanislas Gaillard said that the company is impressed by the group’s quality in positioning, business model and its management team. The company supports the group’s perpetual development in its business, growth and expansion into other segments.

Vulcain Ingénierie’s co-CEOs, Frederic Grard and Alban Guilloteau acknowledged NiXEN and Initiative and Finance for their support over the past five years. It was due to their support that Vulcain was able to completely implement its strategic plans and confirm its position as a company that has specialized in consulting and engineering.

The company’s sole focus on the infrastructure sector, energy and erocess Industries has reinforced their position as an employer and gained recognition from diverse and loyal customers.

Vulcain expects to launch a new cycle of investment and development that will help strengthen their business expertise, reinforce their regional network and expand the international footprint of the Group. The Group is convinced that Equistone, a leading mid-market firm, will provide the company the support and resources it requires to achieve its goals, added the CEOs.

NiXEN Partner’s President, Jean-Paul Bernardini said that the deal with Equistone is a significant step led by the managing team, owing to a strong commercial development and the string of successful external growth operations done abroad and in France.

 

Source Credit- https://www.pehub.com/2019/06/equistone-partners-to-buy-vulcain-Ingénierie/

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fractyl raises series E funding of USD 55 million for diabetes cure
Fractyl raises series E funding of USD 55 million for diabetes cure
By Nikita Chaurasia

Fractyl Laboratories raised series E funding of USD 55 million to continue financing the pivotal clinical trial of its potential non-surgical, non-drug treatment for Type 2 diabetes. As per the trusted sources, the capital will be invested on mass-b...

Nokia Corp. partners with IISc to improve telecommunication solutions
Nokia Corp. partners with IISc to improve telecommunication solutions
By Nikita Chaurasia

Finnish multinational telecommunications giant Nokia Corporation has recently made it to the headlines after entering into a joint venture agreement with IISc (Indian Institute of Science) to launch the Nokia CoE (Centre of excellence) for Networked ...

Motorola acquires Pelco Inc. to expand its video security services
Motorola acquires Pelco Inc. to expand its video security services
By Nikita Chaurasia

Chicago-based telecommunication company, Motorola Solutions Inc., has made it to the headlines through its acquisition of Pelco Inc. from Transom Capital Group for $110 million dollars. For those uninitiated, Pelco Inc. is a security and surveillanc...

NeuroRx, Relief Therapeutics declare results of RLF-100 clinical trials
NeuroRx, Relief Therapeutics declare results of RLF-100 clinical trials
By Nikita Chaurasia

U.S.-based pharmaceutical company NeuroRx Inc., along with Relief Therapeutics Holding AG, a Swiss drug development company, have reportedly declared that aviptadil (RLF-100) clinical trials have showcased quick recuperation of respiratory failures a...

Boehringer Ingelheim acquires GST to expand stem cell capabilities
Boehringer Ingelheim acquires GST to expand stem cell capabilities
By Nikita Chaurasia

Boehringer Ingelheim, a leader in pharmaceutical products, has recently made it to the headlines by acquiring Belgium-based veterinary biotech firm, Global Stem cell Technology (GST). According to reliable sources, the collaboration with GST will al...